JP4846565B2 - 近接照射療法用の製品及び方法 - Google Patents
近接照射療法用の製品及び方法 Download PDFInfo
- Publication number
- JP4846565B2 JP4846565B2 JP2006507253A JP2006507253A JP4846565B2 JP 4846565 B2 JP4846565 B2 JP 4846565B2 JP 2006507253 A JP2006507253 A JP 2006507253A JP 2006507253 A JP2006507253 A JP 2006507253A JP 4846565 B2 JP4846565 B2 JP 4846565B2
- Authority
- JP
- Japan
- Prior art keywords
- radioactive
- suture
- spacer
- seed
- needle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002725 brachytherapy Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title abstract description 29
- 230000002285 radioactive effect Effects 0.000 claims abstract description 151
- 125000006850 spacer group Chemical group 0.000 claims abstract description 63
- 230000005855 radiation Effects 0.000 claims description 35
- 239000002245 particle Substances 0.000 claims description 7
- 229920000954 Polyglycolide Polymers 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 5
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000000622 polydioxanone Substances 0.000 claims description 3
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims description 2
- 235000005811 Viola adunca Nutrition 0.000 claims 1
- 240000009038 Viola odorata Species 0.000 claims 1
- 235000013487 Viola odorata Nutrition 0.000 claims 1
- 235000002254 Viola papilionacea Nutrition 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 19
- 238000004519 manufacturing process Methods 0.000 abstract description 12
- 206010060862 Prostate cancer Diseases 0.000 abstract description 9
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract description 9
- 238000003780 insertion Methods 0.000 description 26
- 230000037431 insertion Effects 0.000 description 26
- 229920000642 polymer Polymers 0.000 description 25
- 239000000203 mixture Substances 0.000 description 15
- 238000010438 heat treatment Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 239000003356 suture material Substances 0.000 description 10
- 210000002307 prostate Anatomy 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000011049 filling Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 238000001125 extrusion Methods 0.000 description 6
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 238000005520 cutting process Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000000945 filler Substances 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000010936 titanium Substances 0.000 description 5
- 208000003174 Brain Neoplasms Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 229940044173 iodine-125 Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- KDLHZDBZIXYQEI-OIOBTWANSA-N palladium-103 Chemical compound [103Pd] KDLHZDBZIXYQEI-OIOBTWANSA-N 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 206010062038 Lip neoplasm Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010062129 Tongue neoplasm Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 239000012611 container material Substances 0.000 description 2
- 238000004980 dosimetry Methods 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 201000010536 head and neck cancer Diseases 0.000 description 2
- 208000014829 head and neck neoplasm Diseases 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 201000006721 lip cancer Diseases 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 231100000647 material safety data sheet Toxicity 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 201000006134 tongue cancer Diseases 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- 206010046885 vaginal cancer Diseases 0.000 description 2
- 208000013139 vaginal neoplasm Diseases 0.000 description 2
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 1
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108010002156 Depsipeptides Proteins 0.000 description 1
- 229910001200 Ferrotitanium Inorganic materials 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-OUBTZVSYSA-N Phosphorus-32 Chemical compound [32P] OAICVXFJPJFONN-OUBTZVSYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- NINIDFKCEFEMDL-AKLPVKDBSA-N Sulfur-35 Chemical compound [35S] NINIDFKCEFEMDL-AKLPVKDBSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- VWQVUPCCIRVNHF-OUBTZVSYSA-N Yttrium-90 Chemical compound [90Y] VWQVUPCCIRVNHF-OUBTZVSYSA-N 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229920005578 aromatic polyanhydride Polymers 0.000 description 1
- RQNWIZPPADIBDY-YPZZEJLDSA-N arsenic-73 Chemical compound [73As] RQNWIZPPADIBDY-YPZZEJLDSA-N 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- TVFDJXOCXUVLDH-YPZZEJLDSA-N cesium-131 Chemical compound [131Cs] TVFDJXOCXUVLDH-YPZZEJLDSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- -1 chromium-56 Chemical compound 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 229920006332 epoxy adhesive Polymers 0.000 description 1
- 238000011347 external beam therapy Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- PCHJSUWPFVWCPO-OUBTZVSYSA-N gold-198 Chemical compound [198Au] PCHJSUWPFVWCPO-OUBTZVSYSA-N 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- GKOZUEZYRPOHIO-IGMARMGPSA-N iridium-192 Chemical compound [192Ir] GKOZUEZYRPOHIO-IGMARMGPSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- JMRZMIFDYMSZCB-UHFFFAOYSA-N morpholine-2,5-dione Chemical compound O=C1COC(=O)CN1 JMRZMIFDYMSZCB-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 125000005702 oxyalkylene group Chemical group 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- KAVGMUDTWQVPDF-UHFFFAOYSA-N perflubutane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F KAVGMUDTWQVPDF-UHFFFAOYSA-N 0.000 description 1
- 229950003332 perflubutane Drugs 0.000 description 1
- 229940097886 phosphorus 32 Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920000117 poly(dioxanone) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012508 resin bead Substances 0.000 description 1
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- CIOAGBVUUVVLOB-OUBTZVSYSA-N strontium-89 Chemical compound [89Sr] CIOAGBVUUVVLOB-OUBTZVSYSA-N 0.000 description 1
- 229940006509 strontium-89 Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- FRNOGLGSGLTDKL-OUBTZVSYSA-N thulium-170 Chemical compound [170Tm] FRNOGLGSGLTDKL-OUBTZVSYSA-N 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- CMHHITPYCHHOGT-UHFFFAOYSA-N tributylborane Chemical compound CCCCB(CCCC)CCCC CMHHITPYCHHOGT-UHFFFAOYSA-N 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1027—Interstitial radiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1023—Means for creating a row of seeds, e.g. spacers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
Description
a)中空生体吸収性縫合糸部材を準備するステップと、
b)複数の放射性シードを準備するステップと、
c)非染色放射性シードとは異なる色に染色され、放射性シードとは直径の異なる複数の生体吸収性スペーサー部材を準備するステップと、
d)放射線シードを、縫合糸材料の融点又は軟化点を超える温度に加熱するステップと、
e)加熱したシードとスペーサー部材を所定のパターンで縫合糸部材上に交互に配置して、縫合糸部材を各線源及びスペーサー部材の周囲に溶融又は変形させるステップと、
f)縫合糸部材が各線源及びスペーサー部材の周囲で凝固又は硬化して各線源が適所にしっかりと保持されるように、縫合糸部材を冷却するステップと
を含む方法が提供される。
a)放射性部材を、スペーサー部材の一箇所で、処方された刺入計画に従って所定の長さに切断するステップと、
b)切断した放射性部材を、処方治療領域への刺入に適した中空刺入針のハブ端に、放射性部材全体が針内に収まるように挿入するステップと、
c)放射性部材の先端が針の栓材に到達するまで、スタイレットで放射性部材を中空刺入針に押し込むステップと、
d)装填した刺入針を、患者の処方治療領域に刺入するステップと、
e)刺入針を放射性部材の周囲から抜去して、放射性部材を患者の処方治療領域に残すステップと
を含む方法が提供される。
a)刺入針を、患者の処方治療領域に刺入するステップと、
b)放射性部材を、スペーサー部材の一箇所で、処方された刺入計画に従って所定の長さに切断するステップと、
c)放射性部材を後充填装置に装填するステップと、
d)後充填装置内の放射性部材を刺入針に移して刺入針ハブに嵌挿するステップと、
e)スタイレットを利用して、放射性部材を後充填装置から刺入針を介して最終的に患者の体内に進めるステップと、
f)刺入針及び後充填装置を抜去するステップと
を含む方法が提供される。
a)内部に長手方向の溝又はスロットを有する細長い好ましくは単一ストランドの生体吸収性縫合糸部材を準備するステップと、
b)複数の放射性シードを準備するステップと、
c)非染色放射性シードとは異なる色に染色され、放射性シードとは直径の異なる複数の生体吸収性スペーサー部材を準備するステップと、
d)放射性シード及びスペーサー部材が溝内にしっかりと保持されるように、放射性シード及びスペーサー部材を縫合糸部材の溝内に逐次又は同時に配置するステップと
を含む方法が提供される。
Claims (11)
- 複数の放射性シードとスペーサー部材とが内部に交互に配置された中空の細長い生体吸収性縫合糸部材を含む近接照射療法用の放射性部材であって、上記スペーサー部材が、非染色放射性シードとは異なる色に染色され、放射性シードとは異なる直径を有しており、当該放射性部材の加熱剛化によってスペーサー部材から色が縫合糸部材に移って縫合糸部材内のスペーサ部材の位置を識別することができる、放射性部材。
- 前記スペーサー部材の直径が放射性シードよりも0.1mm〜0.5mm小さい、請求項1記載の放射性部材。
- 前記スペーサー部材が青紫色に染色されている、請求項1又は請求項2記載の放射性部材。
- 縫合糸部材がポリ(グリコール酸)、ポリ(乳酸)、グリコール酸もしくは乳酸のポリエステルアミド、又はポリジオキサノンを含む、請求項1乃至請求項3のいずれか1項記載の放射性部材。
- 縫合糸部材の断面が略円形である、請求項1乃至請求項4のいずれか1項記載の放射性部材。
- 縫合糸部材の断面が少なくとも1つの平坦面を有することを特徴とする、請求項1乃至請求項4のいずれか1項記載の放射性部材。
- 縫合糸部材の断面が略多角形、好ましくは略八角形、四角形又は三角形である、請求項1乃至請求項4のいずれか1項記載の放射性部材。
- 縫合糸部材が超音波反射性の粒子又は気泡を含む、請求項1乃至請求項7のいずれか1項記載の放射性部材。
- ホイール又は治具に装填された請求項1乃至請求項8のいずれか1項記載の放射性部材。
- 前記ホイール又は治具が遮蔽されている、請求項9記載の放射性部材。
- 1以上の放射性シードとスペーサー部材とが内部に交互に離隔して配置された1以上のスロットを備える中空の細長い生体吸収性縫合糸部材を含む近接照射療法用の放射性部材であって、上記スペーサー部材が非染色放射性シードとは異なる色に染色され、放射性シードとは異なる直径を有しており、当該放射性部材の加熱剛化によってスペーサー部材から色が縫合糸部材に移って縫合糸部材内のスペーサ部材の位置を識別することができる、放射性部材。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/390,506 US7322928B2 (en) | 2003-03-17 | 2003-03-17 | Products and methods for brachytherapy |
US10/390,506 | 2003-03-17 | ||
PCT/US2004/008084 WO2004082762A1 (en) | 2003-03-17 | 2004-03-17 | Products and methods for brachytherapy |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006520644A JP2006520644A (ja) | 2006-09-14 |
JP4846565B2 true JP4846565B2 (ja) | 2011-12-28 |
Family
ID=32987545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006507253A Expired - Fee Related JP4846565B2 (ja) | 2003-03-17 | 2004-03-17 | 近接照射療法用の製品及び方法 |
Country Status (11)
Country | Link |
---|---|
US (2) | US7322928B2 (ja) |
EP (1) | EP1610867B1 (ja) |
JP (1) | JP4846565B2 (ja) |
CN (1) | CN100581618C (ja) |
AT (1) | ATE541613T1 (ja) |
BR (1) | BRPI0407970B8 (ja) |
CA (1) | CA2517444C (ja) |
DK (1) | DK1610867T3 (ja) |
ES (1) | ES2377403T3 (ja) |
MX (1) | MXPA05009802A (ja) |
WO (1) | WO2004082762A1 (ja) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026111A2 (en) | 2000-11-16 | 2004-04-01 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
US7074291B2 (en) | 2001-11-02 | 2006-07-11 | Worldwide Medical Technologies, L.L.C. | Delivery system and method for interstitial radiation therapy using strands constructed with extruded strand housings |
US7060020B2 (en) | 2001-11-02 | 2006-06-13 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy |
US6761680B2 (en) * | 2001-11-02 | 2004-07-13 | Richard A. Terwilliger | Delivery system and method for interstitial radiation therapy using seed strands constructed with preformed strand housing |
US6997862B2 (en) * | 2003-05-13 | 2006-02-14 | Ideamatrix, Inc. | Delivery system and method for interstitial radiation therapy using seed strands with custom end spacing |
WO2005018468A2 (en) * | 2003-08-11 | 2005-03-03 | Wilson-Cook Medical Inc. | Surgical implant |
DE102005006718A1 (de) * | 2005-02-04 | 2006-08-17 | Aesculap Ag & Co. Kg | Resorbierbares chirurgisches Nahtmaterial |
US8187159B2 (en) | 2005-07-22 | 2012-05-29 | Biocompatibles, UK | Therapeutic member including a rail used in brachytherapy and other radiation therapy |
US7736293B2 (en) * | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
WO2007053823A2 (en) * | 2005-10-31 | 2007-05-10 | Biolucent, Inc. | Brachytherapy apparatus and methods of using same |
US7988611B2 (en) * | 2006-05-09 | 2011-08-02 | Biocompatibles Uk Limited | After-loader for positioning implants for needle delivery in brachytherapy and other radiation therapy |
US20090216063A1 (en) * | 2008-01-29 | 2009-08-27 | Biocompatibles Uk Limited | Bio-absorbable brachytherapy strands |
WO2008027402A2 (en) * | 2006-08-29 | 2008-03-06 | Civatech Oncology | Brachytherapy devices and related methods and computer program products |
US7874976B1 (en) | 2006-09-07 | 2011-01-25 | Biocompatibles Uk Limited | Echogenic strands and spacers therein |
US7878964B1 (en) | 2006-09-07 | 2011-02-01 | Biocompatibles Uk Limited | Echogenic spacers and strands |
WO2008124778A2 (en) * | 2007-04-09 | 2008-10-16 | George Fred Harder | Hybrid source containing multi-radionuclides for use in radiation therapy |
ES2440743T3 (es) * | 2007-07-02 | 2014-01-30 | Medi-Physics, Inc. | Hebra de braquiterapia reforzada con adhesivo |
US20090259251A1 (en) * | 2008-04-11 | 2009-10-15 | Cohen Matthew D | Loop suture |
EP2293842B1 (en) | 2008-05-02 | 2020-08-12 | Civatech Oncology | Brachytherapy devices and related methods |
US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
DK200970073A (en) * | 2009-07-22 | 2011-01-23 | Coloplast As | Suturing system and assembly |
US20110046642A1 (en) * | 2009-08-21 | 2011-02-24 | Coloplast A/S | Suture assembly and system |
US20120259153A1 (en) * | 2009-10-21 | 2012-10-11 | The University Of North Carolina At Chapel Hill | Delivery systems for brachytherapy, and associated methods |
BR112012015204A2 (pt) * | 2009-12-23 | 2019-09-24 | Medi Physics Inc | "dispositivo de braquiterapia, braçadeira de braquiterapia, kit,e, método para inserir uma agulha de braquiterapia em um paciente". |
EP2549933A4 (en) * | 2010-03-25 | 2015-10-14 | Covidien Lp | CHEMICAL KNOTS FOR SEAMS |
US8968362B2 (en) | 2010-04-08 | 2015-03-03 | Covidien Lp | Coated looped suture |
WO2011163368A1 (en) * | 2010-06-24 | 2011-12-29 | Cdw Investments, Llc | Hyperechogenic needles |
WO2012061348A2 (en) * | 2010-11-01 | 2012-05-10 | Civatech Oncology | Brachytherapy devices and related methods providing bioaborbability and/or asymmetric irradiation |
US8992550B2 (en) * | 2011-07-20 | 2015-03-31 | Coloplast A/S | Suture system with capsule eyelet providing multiple suture tissue fixation |
US9877727B2 (en) | 2013-05-02 | 2018-01-30 | Empire Technology Development Llc | Diverticulum treating device |
CN103736200B (zh) * | 2013-12-31 | 2016-08-17 | 原子高科股份有限公司 | 一种放射性粒子链的制备方法 |
CN105920727A (zh) * | 2016-04-11 | 2016-09-07 | 王娟 | 一种放射性粒子链及其使用方法 |
AU2017316682B2 (en) | 2016-08-24 | 2020-10-15 | Arthrex, Inc. | Tissue use for repair of injury |
US11298846B1 (en) * | 2017-11-02 | 2022-04-12 | Isoray Medical, Inc. | Cutting device for brachytherapy seed implantation sleeves |
WO2019171308A1 (en) | 2018-03-08 | 2019-09-12 | Alpha Tau Medical Ltd. | Radiotherapy seeds and applicators |
CN109173092A (zh) * | 2018-09-25 | 2019-01-11 | 天津赛德医药研究院有限公司 | 一种易从体内取出的内放疗器 |
CN109173091A (zh) * | 2018-09-25 | 2019-01-11 | 天津赛德医药研究院有限公司 | 一种易从体内取出的内放疗装置 |
CN109513117A (zh) * | 2018-09-25 | 2019-03-26 | 天津赛德生物制药有限公司 | 简易的易从体内取出的内放疗装置 |
CN109316668A (zh) * | 2018-09-25 | 2019-02-12 | 协和生物制药(天津)有限公司 | 一种易从体内取出的内放射治疗装置 |
US11511017B2 (en) | 2019-03-12 | 2022-11-29 | Arthrex, Inc. | Ligament reconstruction |
CA3189134A1 (en) * | 2020-08-10 | 2022-02-17 | Charles Martin Iii | Biodegradable adhesive with radioisotopes |
US20240424154A1 (en) * | 2021-08-23 | 2024-12-26 | AdvanCell Isotopes Pty Limited | Materials and processes for generating radioisotopes |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5460592A (en) * | 1994-01-24 | 1995-10-24 | Amersham Holdings, Inc. | Apparatus and method for making carrier assembly for radioactive seed carrier |
US5938583A (en) * | 1997-12-29 | 1999-08-17 | Grimm; Peter D. | Precision implant needle and method of using same in seed implant treatment of prostate cancer |
JP2002541996A (ja) * | 1999-04-28 | 2002-12-10 | メディ−フィジックス・インコーポレイテッド | 小線源治療用の製品及び治療方法 |
US6572525B1 (en) * | 2000-05-26 | 2003-06-03 | Lisa Yoshizumi | Needle having an aperture for detecting seeds or spacers loaded therein and colored seeds or spacers |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2703316A (en) | 1951-06-05 | 1955-03-01 | Du Pont | Polymers of high melting lactide |
US2668162A (en) | 1952-03-20 | 1954-02-02 | Du Pont | Preparation of high molecular weight polyhydroxyacetic ester |
US2758987A (en) | 1952-06-05 | 1956-08-14 | Du Pont | Optically active homopolymers containing but one antipodal species of an alpha-monohydroxy monocarboxylic acid |
US3297033A (en) | 1963-10-31 | 1967-01-10 | American Cyanamid Co | Surgical sutures |
US3351049A (en) | 1965-04-12 | 1967-11-07 | Hazleton Nuclear Science Corp | Therapeutic metal seed containing within a radioactive isotope disposed on a carrier and method of manufacture |
BE758156R (fr) | 1970-05-13 | 1971-04-28 | Ethicon Inc | Element de suture absorbable et sa |
US3839297A (en) | 1971-11-22 | 1974-10-01 | Ethicon Inc | Use of stannous octoate catalyst in the manufacture of l(-)lactide-glycolide copolymer sutures |
US4141087A (en) | 1977-01-19 | 1979-02-27 | Ethicon, Inc. | Isomorphic copolyoxalates and sutures thereof |
US4323055A (en) | 1980-04-08 | 1982-04-06 | Minnesota Mining And Manufacturing Company | Radioactive iodine seed |
US4509506A (en) * | 1981-05-11 | 1985-04-09 | Minnesota Mining & Manufacturing Co. | Shielding device for radioactive seed |
US4689424A (en) | 1981-08-06 | 1987-08-25 | Ethicon, Inc. | Radiation sterilizable absorbable polymeric materials and methods for manufacturing the same |
US4441496A (en) | 1982-02-08 | 1984-04-10 | Ethicon, Inc. | Copolymers of p-dioxanone and 2,5-morpholinediones and surgical devices formed therefrom having accelerated absorption characteristics |
US4452973A (en) | 1982-11-12 | 1984-06-05 | American Cyanamid Company | Poly(glycolic acid)/poly(oxyethylene) triblock copolymers and method of manufacturing the same |
US4473670A (en) | 1983-05-25 | 1984-09-25 | Ethicon, Inc. | Salt-filled absorbable polymers |
US4502988A (en) | 1983-08-08 | 1985-03-05 | Eli Lilly And Company | Oxidation process |
US4612923A (en) | 1983-12-01 | 1986-09-23 | Ethicon, Inc. | Glass-filled, absorbable surgical devices |
US4646741A (en) | 1984-11-09 | 1987-03-03 | Ethicon, Inc. | Surgical fastener made from polymeric blends |
US4702228A (en) | 1985-01-24 | 1987-10-27 | Theragenics Corporation | X-ray-emitting interstitial implants |
US4741337A (en) | 1985-07-17 | 1988-05-03 | Ethicon, Inc. | Surgical fastener made from glycolide-rich polymer blends |
JPS6323670A (ja) | 1986-04-25 | 1988-01-30 | バイオ−ポリマ−ズ インコ−ポレ−テツド | 接着・被覆組成物とその使用方法 |
US4916209A (en) | 1987-12-23 | 1990-04-10 | Pfizer Inc. | Bioabsorbable polydepsipeptide, preparation and use thereof |
JP2740358B2 (ja) | 1991-02-04 | 1998-04-15 | シャープ株式会社 | パターン設計用cad装置 |
AU2317592A (en) | 1991-07-05 | 1993-02-11 | University Of Rochester | Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
JPH0517499A (ja) | 1991-07-09 | 1993-01-26 | Hitachi Chem Co Ltd | 新規ヘプタペプチド及びその不溶化方法 |
GB9116610D0 (en) | 1991-08-01 | 1991-09-18 | Danbiosyst Uk | Preparation of microparticles |
US5264540A (en) | 1992-07-20 | 1993-11-23 | Ethicon, Inc. | Aromatic polyanhydrides |
US5397816A (en) | 1992-11-17 | 1995-03-14 | Ethicon, Inc. | Reinforced absorbable polymers |
US6019718A (en) * | 1997-05-30 | 2000-02-01 | Scimed Life Systems, Inc. | Apparatus for intravascular radioactive treatment |
EP1155418B1 (en) * | 1999-02-25 | 2007-04-11 | GE Healthcare Limited | Medical tools and devices with improved ultrasound visibility |
US6264600B1 (en) | 1999-10-21 | 2001-07-24 | Peter D. Grimm | Hollow suture member with radioactive seeds positioned therein for treatment of prostate cancer |
CA2388844A1 (en) * | 1999-11-12 | 2001-05-25 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors |
PL203978B1 (pl) | 2000-11-01 | 2009-11-30 | Medi Physics Inc | Sposób wytwarzania elementu radioaktywnego |
WO2004026111A2 (en) * | 2000-11-16 | 2004-04-01 | Microspherix Llc | Flexible and/or elastic brachytherapy seed or strand |
DE10204818C2 (de) * | 2002-02-06 | 2003-11-27 | Eurotope Entwicklungsgesellsch | Gerät und Verfahren zur Beladung von Implantationshohlnadeln mit Strahlungsquellen aus Strahlungsquellenketten zur interstitiellen Brachytherapie von Gewebe |
FR2844714B1 (fr) | 2002-09-20 | 2007-04-27 | Af Consulting | Compositions pour les soins de la peau subissant un desequilibre hormonal, et contenant un ou des oligomeres de resveratrol, en particulier de l'epsilone-viniferine, et/ou certains de leurs derives |
-
2003
- 2003-03-17 US US10/390,506 patent/US7322928B2/en active Active
-
2004
- 2004-03-17 MX MXPA05009802A patent/MXPA05009802A/es active IP Right Grant
- 2004-03-17 BR BRPI0407970A patent/BRPI0407970B8/pt not_active IP Right Cessation
- 2004-03-17 EP EP04757539A patent/EP1610867B1/en not_active Expired - Lifetime
- 2004-03-17 CA CA2517444A patent/CA2517444C/en not_active Expired - Fee Related
- 2004-03-17 WO PCT/US2004/008084 patent/WO2004082762A1/en active Application Filing
- 2004-03-17 DK DK04757539.4T patent/DK1610867T3/da active
- 2004-03-17 CN CN200480007120A patent/CN100581618C/zh not_active Expired - Fee Related
- 2004-03-17 AT AT04757539T patent/ATE541613T1/de active
- 2004-03-17 ES ES04757539T patent/ES2377403T3/es not_active Expired - Lifetime
- 2004-03-17 JP JP2006507253A patent/JP4846565B2/ja not_active Expired - Fee Related
-
2007
- 2007-12-19 US US11/959,687 patent/US8007427B2/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5460592A (en) * | 1994-01-24 | 1995-10-24 | Amersham Holdings, Inc. | Apparatus and method for making carrier assembly for radioactive seed carrier |
US5938583A (en) * | 1997-12-29 | 1999-08-17 | Grimm; Peter D. | Precision implant needle and method of using same in seed implant treatment of prostate cancer |
JP2002541996A (ja) * | 1999-04-28 | 2002-12-10 | メディ−フィジックス・インコーポレイテッド | 小線源治療用の製品及び治療方法 |
US6572525B1 (en) * | 2000-05-26 | 2003-06-03 | Lisa Yoshizumi | Needle having an aperture for detecting seeds or spacers loaded therein and colored seeds or spacers |
Also Published As
Publication number | Publication date |
---|---|
US20080097140A1 (en) | 2008-04-24 |
EP1610867B1 (en) | 2012-01-18 |
CN100581618C (zh) | 2010-01-20 |
ES2377403T3 (es) | 2012-03-27 |
BRPI0407970B8 (pt) | 2021-06-22 |
CA2517444C (en) | 2012-06-19 |
MXPA05009802A (es) | 2005-10-26 |
JP2006520644A (ja) | 2006-09-14 |
BRPI0407970B1 (pt) | 2015-11-24 |
EP1610867A1 (en) | 2006-01-04 |
WO2004082762A1 (en) | 2004-09-30 |
ATE541613T1 (de) | 2012-02-15 |
BRPI0407970A (pt) | 2006-03-07 |
DK1610867T3 (da) | 2012-03-19 |
CA2517444A1 (en) | 2004-09-30 |
CN1761500A (zh) | 2006-04-19 |
US20040186340A1 (en) | 2004-09-23 |
US8007427B2 (en) | 2011-08-30 |
US7322928B2 (en) | 2008-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4846565B2 (ja) | 近接照射療法用の製品及び方法 | |
JP4349547B2 (ja) | 小線源治療用の製品及び治療方法 | |
US7547274B2 (en) | Radioactive member and method of making | |
AU2002231227A1 (en) | Radioactive member for use in brachytherapy and method of making | |
US4706652A (en) | Temporary radiation therapy | |
EP0292630A1 (en) | Radiation therapy delivery systems | |
BRPI0904414A2 (pt) | processo de fabricação de encapsulamento polimérico na construção de sementes para uso em braquiterapia, e sua utilização |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070313 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20091020 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100120 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20100120 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20100120 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100127 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100219 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100226 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100319 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100329 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100419 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100518 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100818 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20100825 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20101015 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101022 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110329 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110511 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110913 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111012 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141021 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4846565 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |